Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Incidence of Diabetes After a COVID-19 Infection - Comparison of COVID-19 Patients, Non-infected Individuals, Historic Controls and Patients With Influenza

NCT05524792 is registered in ClinicalTrials.gov with InGef - Institute for Applied Health Research Berlin GmbH as lead sponsor.

NCT NCT05524792
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05524792 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Incidence of Diabetes After a COVID-19 Infection - Comparison of COVID-19 Patients, Non-infected Individuals, Historic Controls and Patients With Influenza
Lead sponsor
InGef - Institute for Applied Health Research Berlin GmbH
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
September 30, 2021
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19, diabetes mellitus